The European Council has approved new rules to regulate the safety of toys, introducing a digital passport to better trace ...

Contrary to popular belief, gray hair might not always be permanent. Scientific discoveries suggest stress, nutritional ...

October 2025 – Sequana Medical NV (Euronext Brussels: SEQUA (the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer ...

Affected staff have entered a 90-day consultation period, with the earliest redundancies due to take effect from March 2026.

Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.

The FDA has accepted MannKind’s supplemental biologics license application (sBLA) for Afrezza (insulin human inhalation ...

The skin, as the body’s largest organ, serves as a dynamic interface between internal systems and environmental influences.

Key points A 55-year-old man with a left-sided goiter and local compression symptoms presented to our endocrinology clinic. He did not have dysphagia, dyspnea, or hoarseness. All laboratory results, ...

Gilead Sciences, Inc. and Kite, a Gilead Company, will demonstrate progress in our commitment to transform how cancer is treated with new data at the European Society for Medical Oncology (ESMO) 2025 ...